A new vesicle-loaded hydrogel system suitable for topical applications: Preparation and characterization

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 14, Issue 3, 2011, Pages 336-346

  Marianecci, Carlotta ^a   Carafa, Maria ^a   di Marzio, Luisa ^b   Rinaldi, Federica ^a   di Meo, Chiara ^a   Alhaique, Franco ^a   Matricardi, Pietro ^a   Coviello, Tommasina ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALGAROBA; CAFFEINE; CALCEIN; DRUG CARRIER; IBUPROFEN; NILE RED; NIOSOME; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG ADSORPTION; DRUG FORMULATION; DRUG RELEASE; EMBEDDING; HYDROGEL; HYDROPHILICITY; IN VITRO STUDY; MOLECULAR SIZE; SCANNING ELECTRON MICROSCOPY; SKIN SURFACE; SKIN TEMPERATURE; SURFACE PROPERTY; TEMPERATURE SENSITIVITY; TOPICAL DRUG ADMINISTRATION; TURBIDITY; ZETA POTENTIAL;

EID: 80052702429     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3160b     Document Type: Article

References (49)

1. Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002; 54: S131-S155.
2. Uchegbu IF, Vyas SP. Non-ionic surfactant vesicles (Niosomes) in drug delivery. Int J Pharm 1998; 17: 33-70.
3. Santucci E, Carafa M, Coviello T, Murtas E, Riccieri FM, Alhaique, F, Modesti A, Modica A. Vesicles from polysorbate 20 and cholesterol. A simple preparation and characterization. STP Pharma Sci. 1996; 6: 29-32.
4. Di Marzio L, Marianecci C, Petrone M, Rinaldi F, Carafa M. Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20 Colloids and Surface B: Biointerfaces 2011; 82: 18-24.
5. ® 20 derivatives enable the formation of efficient pH-sensitive drug delivery vehicles for human hepatoblastoma. Bioorganic & Medicinal Chemistry Letters 2010; 2: 3021-3025.
6. Maibach HI, Choi MJ. Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol 2005; 18: 209-219.
7. L'Oréal S, (1975) Procédé de fabrication de dispersions aqueuses de spérules lipidiques et nouvelles compositions correspondantes French Patent 2315991
8. L'Oréal S, (1989) Cosmetic and pharmaceutical compositions containing niosomes and a watersoluble polyamide, and a process for preparing these compositions, US Patent 4830857.
9. Carafa M, Marianecci C, Lucania G, Marchei E, Santucci E. New vesicular ampicillin-loaded delivery systems for topical application: characterization, in vitro permeation experiments and antimicrobial activity. J Contr. Rel. 2004; 95:67-74.
10. Scott DC, Clymer JW Estimation of Distribution Coefficients from the Partition Coefficient and pKa. www.pharmtech.com 2002.
11. Kaliszan R, Haber P, Tomasz B, Siluk D, Valko K Lipophilicity and pKa estimates from gradient high-performance liquid chromatography J. Chrom. A, 2002; 965: 117-127
12. Coviello T, Matricard P, Marianecci C, Alhaique F Polysaccharide hydrogels for modified release formulations. J. Control. Release, 2007; 119: 5-24.
13. Coviello T, Matricardi P, Alhaique F Drug delivery strategies using polysaccharidic gels. Expert Opin. Drug Deliv. 2006; 3: 395-404.
14. Morris, E.R., Mixed polymer gels. In P. Harris (Ed.). Food Gels. Elsevier London, UK, pp 291-359, 1990.
15. Coviello T, Kajiwara K, Burchard W, Dentini M, Crescenzi V. Solution properties of Xanthan. 1. Dynamic and static light scattering from native and modified Xanthans in dilute solutions. Macromolecules, 1986; 19: 2826-2831.
16. Crescenzi V, Dentini M, Coviello T Solution and gelling properties of polysaccharide polyelectrolytes Biophys. Chem. 1991; 41: 61-71.
17. Lundin L, Hermansson A. M. Supermolecular aspects of Xanthan-locust bean gum gels based on rheology and electron microscopy. Carbohydrate Polymers 1995; 26: 129-140.
18. Richter S, Boyko V, Matzker R, Schröter K. Gelation studies: comparison of the critical exponents obtained by dynamic light scattering and rheology, 2a A thermoreversible gelling system: mixtures of xanthan gum locust bean gum. Macromolecular Rapid Communication 2004; 25: 1504-1509.
19. Richter S, Brand T, Berger S. Comparative monitoring of the gelation process of a Thermoreversible gelling system made of xanthan gum and locust bean gum by dynamic light scattering and 1H NMR spectroscopy. Macromolecular Rapid Communication 2005; 26: 548-553.
20. Wang E, Wang Y J, Sun Z. Conformational role of xanthan in its interaction with locust bean gum. Journal of Food Science 2002; 67: 2609-2614.
21. Zhan DF, Ridout MJ, Brownsey G J, Morris V J Xanthan-locust bean gum interactions and gelation. Carbohydrate Polymers 1993; 21: 53-58.
22. Dolz M, Her Delegido J, Alfaro M C, Muňoz J. Influence of xanthan gum and locust bean gum upon flow and thixotropic behaviour of food emulsions containing modified starch. Journal of Food Engineering, 2007; 81: 179-186.
23. Mandala I, Kapetanakou A, Kostaropoulos A. Physical properties of breads containing hydrocolloids stored at low temperature: II-Effect of freezing. Food Hydrocolloids 2008; 22: 1443-1451.
24. Pedersen J K Carrageenan, pectin and xanthan/locust bean gum gels. Trends in their food use. Food Chemistry 1980; 6: 77-88.
25. Sahin H, Ozdemir F. Effect of some hydrocolloids on the rheological properties of different formulated ketchups. Food Hydrocolloids 2004; 18: 1015-1022.
26. Ramírez J A, Barrera M, Morales OG, Vázquez M. Efefct of xanthan and locust bean gums on the gelling properties of myofibrillar protein. Food Hydrocolloids 2002; 16: 11-16.
27. Secouard S, Malhiac C, Grisel M, Decroix B. Release of limonene from polysaccharide matrices: viscosity and synergy effect. Food Chemistry 2003; 82: 2227-234.
28. Baichwal, AR (2004). Sustained-release matrix for high-dose insoluble drugs. US Patent Office, Pat. No. 2004121012.
29. Fadden DJ, Kulkarni NM, Sorg AF (2004). Fast dissolving orally consumable films containing a modified starch for improved heat moisture resistance. US Patent Office, Pat. No. 2004247648.
30. Mannion RO., Melia C D., Mitchell JR., Harding SE., Green AP. Effect of xanthan/locust bean gum synergy on ibuprofen release from hydrophilic matrix tablets. Journal of Pharmacy and Pharmacology 1991; S 43: 79P-79P.
31. Rolf D (2003). Aqueous gel wound dressing and package. US Patent Office, Pat. No. 6620436.
32. Sugden K. (1989). Buccal etorphine tablets with xanthan and locust bean gums. US Patent Office, Pat. No. 4829056.
33. Ughini F, Andreazza IF, Ganter JLMS, Bresolin TMB. Evaluation of Xanthan and highly substituted galactomannan from M. scabrella as a sustained release matrix. Int. J. Pharm. 2004; 271: 197-205.
34. Venkataraju MP, Gowda DV, Rajesh KS, Shivakumar HG. Xanthan and locust bean gum (from Ceratonia siliqua) matrix tablets for oral controlled delivery of metoprolol tartrate. Current Drug Therapy 2008; 3: 70-77.
35. Coviello T, Alhaique F, Dorigo A, Matricardi P, Grassi M. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies Eur. J. Pharm. Biopharm. 2007; 66: 200-209.
36. Sandolo C, Bulone D, Mangione M, Margheritelli S, Di Meo C, Alhaique F, Matricardi P, Coviello T. Synergistic interaction of Locust Bean Gum and Xanthan investigated by rheology and light scattering Carboydr. Polym. 2010; 82: 733-741.
37. Kok M S, Hill SE, Mitchell J R. Viscosity of galactomannans during high temperature processing: influence of degradation and solubilisation. Food Hydrocolloids 1999;13: 535-542.
38. Centis V, Vermette P. Physico-chemical properties and cytotoxicity assessment of PEG-modified liposomes containing human hemoglobin. Colloids Surf B Biointerfaces 2008; 65:239-246
39. Mohammed AR, Weston N, Coombes AGA, Fitzgerald M, Perrie Y. Liposome formulation of poorly water-soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int J Pharm 2004; 285:23-34.
40. Khazaeli P, Pardakhty A, Shoorabi H. Caffeineloaded niosomes: characterization and in vitro release studies. Drug Delivery 2007; 14: 447-452.
41. Saettone MF, Perini G, Carafa M, Santucci E, Alhaique F. Non-ionic surfactant vesicles as ophthalmic carriers for cyclopentolate. A preliminary evaluation. S. T. P. Pharma.Sci. 1996; 6:94-98
42. Terzano C, Allegra L, Alhaique F, Marianecci C, Carafa M. Non phospholipid vesicles for pulmonary glucocorticoid delivery Eur. J. Pharm. Biopharm. 2005; 59: 57-62.
43. Marianecci C, Paolino D, Celia C, Fresta M, Carafa M, Alhaique F. Non-ionic Surfactant Vesicles, Beclomethasone Dipropionate, Pulmonary Drug Carrier, Primary Human Lung Fibroblasts, Carrier-cell interaction, Antiinflammatory activity Journal of Controlled Release 2010; 147: 127-135.
44. Carafa M, Marianecci C, Rinaldi F, Santucci E, Tampucci S, Monti D Span and Tween neutral and pH-sensitive vesicles: characterization and in vitro skin permeation. J Liposome Res. 2009; 19:332-340.
45. Hosny KM. Optimization of gatifloxacin liposomal hydrogel for enhanced transcorneal permeation J. Lip. Res. 2010; 20: 31-37
46. Kapadia R, Khambete H, Katara R, Ramteke S A. Novel Approach For Ocular Delivery of Acyclovir Via Niosomes Entrapped In Situ Hydrogel System J. Pharm. Res. 2009; 2: 745-751
47. Fang JY, Hsu SH, Leu YL, Hu JW Delivery of cisplatin from pluronic co-polymer systems: Liposome inclusion and alginate coupling J. Biomat. Sci., Polymer Edition 2009; 20: 1031-1047
48. Alcantar N, Williams EC, Toomey R. Niosome-Hydrogel Drug Delivery. System Patent US 2010068264 2010)
49. Sandolo C, Coviello T, Matricardi P, Alhaique F. Characterization of polysaccharide hydrogels for modified drug delivery Eur. Biophys. J.2007; 36: 693-700